Congressional Stock Trades & Disclosures
James B. Renacci is a U.S. Representative, a Republican representing OH. As of January 2019, Quantellect has tracked 5,581 disclosed stock trades across 874 companies, representing $128M in disclosed transaction value, each filed publicly under the STOCK Act.

Trading summary
James B. Renacci
- Member Score
- Unavailable
- Measured score unavailable
- Standing
- Rank unavailable
- Profit win rate (2Y)
- —
- No priced buy results available
- vs S&P 500 (2Y)
- —
- +$0 estimated excess profit
- Latest disclosed trade
- Sell · GMAB
- Traded 12 DEC 2018 · Disclosed 02 JAN 2019
About Renacci's congressional trading
Renacci's disclosed activity shows more purchases than sales, with 3,077 purchases and 2,504 sales (a buy-to-sell ratio of 1.23). The heaviest sector is Healthcare, covering 642 disclosed trades.
Renacci's most frequently disclosed positions are AAPL (55 disclosed trades), ICE (53 disclosed trades), MON (49 disclosed trades), BIIB (47 disclosed trades), and AXP (46 disclosed trades), followed by CMCSA, UNP, CELG, GILD, and DAL.
Renacci's most recent disclosed trade was a sale of Genmab AS (GMAB) from December 2018. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Estimated trading profits
The 2Y view uses the same buy-only, priced trade inputs as the Member Score.
Based on 2,672 of 3,085 disclosed buys with pricing coverage.
Aug 4, 2012 to Nov 20, 2026
No priced buy disclosures in this window.
No priced buy disclosures in this window.
No priced buy disclosures in this window.
No priced buy disclosures in this window.
No priced buy disclosures in this window.
No priced buy disclosures in this window.
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Where the Money Sits
share of disclosed trades · top sectors
Periodic Transaction Report filings
Latest congress trades we've covered
- Ted Cruz disclosed a $250,001 - $500,000 Goldman Sachs Group Inc sell
- Thomas H. Kean, Jr. disclosed a $15,001 - $50,000 Microsoft Corporation sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Warner Bros Discovery Inc sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Warner Bros Discovery Inc sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Stryker Corporation sell
- Thomas H. Kean, Jr. disclosed a $1,001 - $15,000 Johnson & Johnson sell
- Steve Cohen disclosed a $1,001 - $15,000 Warner Bros Discovery Inc sell
- Michael A. Rulli disclosed a $1,001 - $15,000 NVIDIA Corporation sell
- Terri A. Sewell disclosed a $1,001 - $15,000 Tapestry Inc sell
- Michael A. Rulli disclosed a $1,001 - $15,000 Lumentum Holdings Inc sell
James B. Renacci congressional trading FAQ
Can James B. Renacci legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles James B. Renacci's disclosures so the public can review them.
Where does Quantellect get James B. Renacci's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track James B. Renacci's stock trades?
Quantellect tracks every stock trade James B. Renacci discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has James B. Renacci disclosed?
Quantellect has tracked 5,581 disclosed trades by James B. Renacci across 874 companies.
Which stocks does James B. Renacci trade most?
James B. Renacci's most frequently disclosed positions are AAPL (55 disclosed trades), ICE (53 disclosed trades), MON (49 disclosed trades), BIIB (47 disclosed trades), AXP (46 disclosed trades), and CMCSA (45 disclosed trades), followed by UNP, CELG, GILD, and DAL. The full list of companies and individual filings is shown on this page.
Which sectors does James B. Renacci invest in?
Healthcare is the heaviest sector in James B. Renacci's classified disclosures, covering 642 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.
What was James B. Renacci's most recent stock disclosure?
James B. Renacci most recently sold Genmab AS (GMAB) in December 2018, according to public STOCK Act filings tracked by Quantellect.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.

